Use of gastrointestinal proton pump inhibitors to regulate osteoclast- mediated resorption of calcium phosphate cements In Vivo

Current Drug Delivery

Volumn 6, Issue 2, 2009, Pages 192-198

  Sheraly, A R ^a   Lickorish, D ^a   Sarraf, F ^b   Davies, J E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone remodeling; Calcium phosphate cements; Proton pump inhibitors

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM PHOSPHATE CERAMIC; OMEPRAZOLE; PANTOPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ION TRANSPORT; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ACID PHOSPHATASE; ANIMALS; BONE CEMENTS; BONE RESORPTION; CALCIUM PHOSPHATES; FEMUR; ISOENZYMES; MALE; OMEPRAZOLE; OSTEOBLASTS; OSTEOCLASTS; PROTON PUMP INHIBITORS; RATS; RATS, WISTAR;

EID: 66749190604     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109787846225     Document Type: Article

References (19)

1. Brown, W.E.; Chow, L.C. Combinations of sparingly soluble calcium phosphates in cement slurries and pastes as remineralizers and cements, US Pat. 461053, 1986.
2. LeGeros, R.Z.; LeGeros, J.P. Calcium phosphate bioceramics: past, present and future. Key Eng. Mater., 2003, 240-242, 3-10.
3. Davies, J.E.; Shapiro, G.; Lowenberg, B.F. Osteoclastic resorption of calcium phosphate ceramic thin films. Cells Mater., 1993, 3, 245-56.
4. Bohner, M.; Lemaitre, J.; van Landuyt, P.; Zambelli, P-Y; Merkle, H.P.; Gander, B. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J. Pharmaceut. Sci., 1997, 86(5), 565-72.
5. Rzeszutek, K.; Sarraf, F.; Davies, J.E. Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth. J. Craniofacial Surg., 2003, 14(3), 301-07.
6. Drose, S.; Altendorf, K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol., 1997, 200, 1-8.
7. Horn, J. The proton-pump inhibitor: similarities and differences. Clin. Ther., 2000, 22(3), 266-80.
8. Shin, M.J.; Sachs, G. Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology, 2002, 123,1588-97.
9. Baron, R.; Neff, L.; Louvard, D.; Courtoy, P.J. Specific localization of a lysosomal membrane protein related to a proton pump at the ruffled border of osteoclasts. Cell Biol., 1983, 97, 416a.
10. Baron, R.; Neff, L.; Louvard, D.; Courtoy, P.J. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. Cell Biol., 1985, 101(6), 2210.
11. +-ATPase, inhibits bone resorption in vitro. Calcified Tissue Int., 1986, 38, 123-25.
12. +-translocating ATPase. Biochim. Biophys. Acta, 1991, 1065, 261-68.
13. +-ATPase, on bone resorption in humans. Calcified Tissue Int., 1993, 53, 21-25.
14. Karp, J.M.; Rzeszutek, K.; Shoichet, M.S.; Davies, J.E. Fabrication of precise cylindrical three-dimensional tissue engineering scaffolds for in vitro and in vivo bone engineering applications. J. Craniofac. Surg., 2003, 14(3), 317-23.
15. Yacyshyn, B.R.; Thomson, A.B.R. The clinical importance of proton pump inhibitor pharmacokinetices. Digestion, 2002, 66, 67-78.
16. Kromer, W.; Kruger, U.; Huber, R.; Hartmann, M.; Steinijans, V.W. Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates. Pharmacology, 1998, 56(2), 57-70.
17. Leitner, A.; Zollner, P. Visual documentation of the stability of intravenous solutions of Omeprazole™ (losec) and Pantoprazole™ (pantoloc). Wiener Med. Wochensch., 2002, 152(21-22), 568-73.
18. Ekpe, A.; Jacobsen, T. Effect of various salts on the stability of lansoprazole, Omeprazole™ and Pantoprazole™ as determined by high-performance liquid chromatography. Drug Dev. Indust. Pharm., 1999, 25(9), 1057-65.
19. DiGiacinto, J.L.; Olsen, K.M.; Bergman, K.L.; Hoie, E.B. Stability of suspension formulations of lansoprazole and Omeprazole™ stored in amber-colored plastic oral syringes. Ann. Pharmacother., 2000, 34, 600-05.